NLS Uncategorized

The first stages of the construction of a new advanced laboratory building in Uppsala have began. Research Hub is a concept for laboratory facilities, designed by C.F. Møller, that addresses small and mid-sized research companies. The concept is flexible, both in terms of size and in function, and it can be quickly adapted to specific […]

The patient, suffering from retinitis pigmentosa, is a participant in the ongoing PIONEER Phase I/II clinical trial of GenSight Biologics’ GS030 optogenetic therapy. These groundbreaking results, from among others biopharma company GenSight Biologics, the Institute of Molecular and Clinical Ophthalmology Basel and the Institut de la Vision at Sorbonne Université/Inserm/CNRS), Paris, were published in Nature […]

New molecules, developed by researchers at Linköping University, have promising properties as possible drugs against epilepsy. A study published in the journal Epilepsia shows that several of the molecules have antiseizure effects, describes Karin Söderlund Leifler/George Farrants at Linköping University. The ion channels thus play a key role in epilepsy In people with epilepsy, the […]

The research leaders have been awarded grants under the Novo Nordisk Foundation Research Leader Programme. One project the grants will fund aims to discover new knowledge on how viruses such as influenza viruses and SARS-CoV-2 (which causes COVID-19) affect the body’s metabolism and whether their proliferation in the body can be combatted. Another project will […]

ISD Immunotech expects to finalize characterization of its STING antagonist lead candidate this year, aiming to develop the first personalized treatment for severe lupus patients. Systemic lupus erythematous (SLE) is a complex and hard-to-treat autoimmune disease with a high unmet medical need. It is the most common and most serious type of lupus, and is […]

Start-up company AdjuTec’s novel antibiotic resistance breakers may help to facilitate reduced use of antibiotics. If there is one positive thing about the COVID-19 pandemic, it could perhaps be our increased awareness of infectious diseases. “The COVID-19 pandemic has been a mind-opener to society’s vulnerability for infectious diseases in general. This includes the importance of […]